Saint Thomas Research Institute
Nashville, Tennessee 37205-2018
4 studies enrolling now · 16 studies all time
What they study most
Brain Cancer, Brain Tumor, CIED Related Infection, GBM, Glioblastoma, Glioblastoma Multiforme, Glioma, Grade IV Astrocytoma, Heart Failure, Heart Failure With Preserved Ejection Fraction (HFpEF), Hypertension, Paroxysmal Atrial Fibrillation (PAF)
Studies at this site
- ELEVATE-HFpEF Clinical Study — Recruiting now
- AMEND TS Early Feasibility Study — Recruiting now
- Lead Evaluation for Defibrillation and Reliability Post Approval Study — Enrolling by invitation
- The Jewel IDE Study — Completed
- Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
- Personalized Therapy Study - HFRS (TriageHF) Post Approval Study — Running, not enrolling
- Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) — Running, not enrolling
- Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
- Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS) — Completed
- Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin — Completed
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer — Status unconfirmed
- Personalized CRT - MPP Post Approval Study — Completed
- Model 4396 Left Ventricular (LV) Lead Chronic Performance Study — Completed
- World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
- Rheos® Pivotal Trial — Completed
- Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 — Available (expanded access)